RNTX

Rein Therapeutics, Inc.

• PUBT·1d ago

  Kymera Therapeutics names Penny Carlson SVP, Development Operations

• Benzinga·06/01 21:06

  12 Health Care Stocks Moving In Monday's After-Market Session

• Dow Jones·06/01 10:52

  Rein Therapeutics Is Maintained at Buy by HC Wainwright & Co.

• Dow Jones·06/01 10:52

  Rein Therapeutics Price Target Cut to $8.00/Share From $10.00 by HC Wainwright & Co.

• Benzinga·06/01 10:42

  HC Wainwright & Co. Maintains Buy on Rein Therapeutics, Lowers Price Target to $8

• Reuters·06/01 10:01

  REIN THERAPEUTICS INC. <RNTX.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $8 FROM $10

• TipRanks·06/01 10:00

  Rein Therapeutics price target lowered to $8 from $10 at H.C. Wainwright

• Reuters·06/01 07:39

  U.S. RESEARCH ROUNDUP-Palomar Holdings, Replimune Group, Snowflake

• PUBT·05/29 00:16

  Rein Therapeutics director Josef H. von Rickenbach acquires $49,525 of common shares

• PUBT·05/28 20:45

  Rein Therapeutics announces annual shareholder meeting

• PUBT·05/18 12:03

  Rein Therapeutics closes $57.5 million follow-on common stock offering

• Reuters·05/18 12:00

  REIN THERAPEUTICS ANNOUNCES CLOSING OF $57.5 MILLION UNDERWRITTEN PUBLIC OFFERING, INCLUDING FULL EXERCISE OF OVER-ALLOTMENT OPTION

• Benzinga·05/15 13:27

  Rein Therapeutics Q1 EPS $(0.19) Beats $(0.49) Estimate

• PUBT·05/15 11:57

  Rein Therapeutics Q1 FY26 net loss widens 6.13% to $5.84 million

• TipRanks·05/14 02:11

  Top Executive Makes Bold Insider Move at Rein Therapeutics